Article ID Journal Published Year Pages File Type
3999399 Urologic Oncology: Seminars and Original Investigations 2016 11 Pages PDF
Abstract
The addition of docetaxel-based chemotherapy to ADT improves OS and clinical PFS in hormone-sensitive metastatic prostate cancer.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Oncology
Preview
Androgen-deprivation therapy plus chemotherapy in metastatic hormone-sensitive prostate cancer. A systematic review and meta-analysis of randomized clinical trials
Authors
, , ,